Mark D Danese (Mark Danese)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 9

Top Venues

Journal of medical economics

Leukemia & lymphoma

Future oncology (London, England)

Hemodialysis international. International Symposium on Home Hemodialysis

Outcomes Insights, Inc

Johns Hopkins University Bloomberg School of Public Health (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Outcomes Insights, Inc Jan 01 2004

United States

President

Education History

Johns Hopkins University Bloomberg School of Public Health Sep 01 1993 - Jun 01 1999

United States

PHD :: Epidemiology

Publications

Mark D Danese, Jennifer Schenfeld, Jaime Shaw, Prasad Gawade, Akhila Balasubramanian, Michael Kelsh, Rohini K Hernandez, Gary Lyman
Association Between Granulocyte Colony-Stimulating Factor (G-CSF) Use and Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Among Elderly Patients with Breast, Lung, or Prostate Cancer. Advances in therapy 39 (6) (2022)
Mark D Danese, Eduard Sidelnikov, Guillermo Villa, David Catterick, Mazhar Iqbal, Michelle Gleeson, Deborah Lubeck, Jeetesh Patel
Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK. BMJ open 12 (4) (2022)
Mark D Danese, Joseph Gricar, Pranav Abraham
Real-world outcomes with second-line therapy in advanced esophageal squamous cell carcinoma using SEER-Medicare data. Future oncology (London, England) 18 (8) (2022)
Joshua A Roth, Yong Yuan, Megan Othus, Mark D Danese, Samuel Wagner, John R Penrod, Scott D Ramsey
A comparison of mixture cure fraction models to traditional parametric survival models in estimation of the cost-effectiveness of nivolumab for relapsed small cell lung cancer. Journal of medical economics 24 (1) (2021)
Geoffrey A Block, Glenn M Chertow, Kerry Cooper, Shan Xing, Bruno Fouqueray, Marc Halperin, Mark D Danese
Fibroblast growth factor 23 as a risk factor for cardiovascular events and mortality in patients in the EVOLVE trial. Hemodialysis international. International Symposium on Home Hemodialysis 25 (1) (2020)
Mark D Danese, Aaron Katz, Karynsa Cetin, Victoria Chia, Michelle L Gleeson, Michael Kelsh, Robert I Griffiths
Treatment patterns, survival, and hospitalization in adult patients with acute lymphoblastic leukemia: an observational cohort study using SEER Medicare data. Leukemia & lymphoma 60 (8) (2019)
Mark D Danese, Marc Halperin, Jennifer Duryea, Ryan Duryea
The Generalized Data Model for clinical research. BMC medical informatics and decision making 19 (1) (2019)
Mark D Danese, Eduard Sidelnikov, Lucie Kutikova
The prevalence, low-density lipoprotein cholesterol levels, and treatment of patients at very high risk of cardiovascular events in the United Kingdom: a cross-sectional study. Current medical research and opinion 34 (8) (2018)
Mark D Danese, Michelle Gleeson, Robert I Griffiths, David Catterick, Lucie Kutikova
Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United Kingdom. Journal of medical economics 20 (9) (2017)

Mark D Danese.css-eqlu8i{font-size:small;padding-left:4px;} (Mark Danese)

Publication Activity (10 Years)

Top Topics

Top Venues

Mark D Danese (Mark Danese)